| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |